The Moscow Exchange has published the official procedure for submitting applications to purchase shares at Genetico’s IPO. Applications will be accepted on the Moscow Exchange from 10 to 12 AM, starting from April 25, 2023. However, orders will only be taken until the issue is completed.
Genetico will offer 10 million shares to investors at RUB 17.88 per share. The minimum lot is 10 shares. The company’s ticker on the Moscow Exchange is GECO. Trading on the secondary market will begin on April 26, 2023.
In accordance with the law, investors can order shares from any broker. To do this, one must submit a transaction order with the necessary parameters in writing or orally on the day of the offering or in advance.
As the demand is high, the Issuer and the Organizer will offer consultations on the order fulfillment procedure. If the number of orders exceeds the offering, investors’ orders may be fulfilled partially. Orders will be fulfilled to ensure the widest possible range of investors participating in the IPO.
The seller of the shares is ALOR+ LLC (trading system ID MC0063100000, trading system short name ALOR+). Issue registration number: 1-01-87198-H.
For details about the offering procedure, please visit the website of the Moscow Exchange - link.
Genetico Center is a resident of Skolkovo, the Medtech Moscow Technopark of the Moscow Center for Innovative Technologies in Healthcare, a subsidiary of the Human Stem Cell Institute (HSCI— MOEX: ISKJ). The company works in the field of medical genetics and genetic research, implementing into medical practice innovative solutions for the diagnosis, prevention, and treatment of genetic and socially significant diseases.
Genetico plans to use the funds raised during its IPO to develop genetic services in Russia, enter foreign markets, register its own test kits, as well as create candidate gene therapy drugs for the treatment of orphan diseases.